Form D · Biotechnology

LSC-BIO HC1, DST

Radnor, PA · CIK 0001725079

Offering snapshot reported Mar 2, 2018 · SEC filing

Reported sold
$4.45M
Offering amount: $4.45M
Investors reported
12
Form D · investor count
Minimum accepted
$25K
Reported outside-investor minimum
First sale
Nov 29, 2017
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$2.23M$4.45MDec 13, 2017: $2,603,701.00Dec 13, 2017Dec 26, 2017: $3,561,610.00Feb 23, 2018: $4,083,610.00Mar 2, 2018: $4,453,890.00Mar 2, 2018

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$4,083,610 → $4,453,890
  • Reported investors11 → 12

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 2, 2018Amendment$4,453,890$370,280vs Feb 23, 201812SEC filing
Feb 23, 2018Amendment$4,083,610$522,000vs Dec 26, 201711SEC filing
Dec 26, 2017Amendment$3,561,610$957,909vs Dec 13, 20177SEC filing
Dec 13, 2017Initial$2,603,701No comparison3SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$575K (estimated)
Finders' fees
$0
Form D file number
021-300625

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
McDermott Investment Services, LLC154926
Taylor Capital Management, Inc.43559
Lion Street Financial, LLC165828
D.H. Hill Securities, LLLP41528
Lighthouse Capital Group, LLC169135
WealthForge Securities, LLC152550

Source: Form D, filed Mar 2, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Livingston Capital, Llc Promoter
Pietro Scola Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
595 East Lancaster Avenue Suite 300
Radnor, PA, 19087